在被怀疑患有局部过敏性鼻炎的受试者中,在自然过敏原暴露期间和经过鼻刺激测试后,鼻洗液中的粉尘特定IgE
Mohamad Mahdi Mortada1, Alaa Sherri2, Edyta Pietrowska3
1Department of Immunology and Allergy, International Doctoral School, Medical University of Łódź, 92-213 Łódź, Poland.
Life (Basel, Switzerland)
|November 27, 2025
概括
局部过敏性鼻炎 (LAR) 涉及鼻腔过敏症状,尽管皮肤测试呈阴性. 这项研究发现,家用粉尘虫过敏原的鼻洗中具有高的特定IgE,这表明在疑似LAR患者中存在局部过敏反应.
科学领域:
- 过敏学和免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 局部过敏性鼻炎 (LAR) 呈现出鼻炎症状,但皮肤刺伤测试 (SPT) 和血清特异性IgE (sIgE) 呈阴性.
- 对LAR的诊断依赖于使用特定过敏原的阳性鼻刺激试验 (NPT).
- 了解LAR的发病过程需要研究鼻腔粘膜中的局部过敏反应.
研究的目的:
- 在怀疑LAR的患者中评估临床症状和局部粘膜sIgE.
- 评估自然暴露和NPT与室内灰尘虫 (HDM) 过敏原对LAR症状和sIgE水平的影响.
- 探索局部sIgE生产在LAR诊断和发病过程中的作用.
主要方法:
- 包括25名涉嫌LAR的受试者.
- 使用总鼻腔症状评分 (TNSS) 和视觉模拟尺度 (VAS) 评估症状.
- 用HDM过敏原进行了NPT,并通过鼻水收集鼻分泌物以测量sIgE水平.
主要成果:
- 在HDM暴露增加的时期,TNSS和VAS显著增加.
- 在鼻水中增加了特定于Dermatophagoides pteronyssinus和Dermatophagoides farinae的sIgE水平.
- 在NPT后的8名受试者中证实了LAR,具有更高的VAS得分和挑战后增加的局部sIgE,尽管并不总是统计学上显著.
结论:
- 当地鼻腔sIgE评估对于了解LAR病原性是有价值的.
- 需要对更大的队列进行进一步的研究,以完善LAR诊断和治疗策略.
- 与sIgE一起研究局部炎症调解剂可能会增强对LAR的知识.
更多相关视频
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
31.8K
08:44Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
6.5K
相关概念视频
Allergic Reactions
31.9K
Overview
31.9K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
